M23-499 PH 2 Spasticity
ClinicalTrials.gov NCT05956509
Research payments
$138,700
Through program year 2024, $138,700 in research payments was reported against M23-499 PH 2 Spasticity, across 9 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT05956509
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $138,700 | 9 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Atul Patel Overland Park, KS Named on 1 payment
- Peter McAllister Fairfield, CT Named on 1 payment
- Fatma Gul Dallas, TX Named on 1 payment
- Joseph Burris Columbia, MO Named on 1 payment
- Gregory Sahagian Carlsbad, CA Named on 1 payment
- Ziyad Ayyoub Paramount, CA Named on 1 payment
- Perminder Bhatia Fresno, CA Named on 1 payment
- Richard Zorowitz Washington, DC Named on 1 payment
- Linda Pao Jupiter, FL Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.